Detalhe da pesquisa
1.
Depth and durability of response to ibrutinib in CLL: 5-year follow-up of a phase 2 study.
Blood
; 131(21): 2357-2366, 2018 05 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-29483101
2.
TP53 mutations identify younger mantle cell lymphoma patients who do not benefit from intensive chemoimmunotherapy.
Blood
; 130(17): 1903-1910, 2017 10 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-28819011
3.
Deep targeted sequencing of TP53 in chronic lymphocytic leukemia: clinical impact at diagnosis and at time of treatment.
Haematologica
; 104(4): 789-796, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30514802
4.
Chronic lymphocytic leukaemia clones are detectable decades before diagnosis.
Br J Haematol
; 196(3): 784-787, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34580859
5.
miR-18b overexpression identifies mantle cell lymphoma patients with poor outcome and improves the MIPI-B prognosticator.
Blood
; 125(17): 2669-77, 2015 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-25736311
6.
15-year follow-up of the Second Nordic Mantle Cell Lymphoma trial (MCL2): prolonged remissions without survival plateau.
Br J Haematol
; 175(3): 410-418, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27378674
7.
Ibrutinib for previously untreated and relapsed or refractory chronic lymphocytic leukaemia with TP53 aberrations: a phase 2, single-arm trial.
Lancet Oncol
; 16(2): 169-76, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25555420
8.
Nordic MCL2 trial update: six-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC + autologous stem-cell support: still very long survival but late relapses do occur.
Br J Haematol
; 158(3): 355-62, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22640180
9.
Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo-purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group.
Blood
; 112(7): 2687-93, 2008 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18625886
10.
Epstein-Barr virus reactivation is a potentially severe complication in chronic lymphocytic leukemia patients with poor prognostic biological markers and fludarabine refractory disease.
Haematologica
; 93(9): 1424-6, 2008 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-18641020
11.
Pre-emptive treatment with rituximab of molecular relapse after autologous stem cell transplantation in mantle cell lymphoma.
J Clin Oncol
; 27(26): 4365-70, 2009 Sep 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-19652064